Regal Funds Management specializes in absolute returns across varying investment cycles.
Business Model:
Revenue: $0
Employees: 0-0
Address: Level 47, Gateway 1 Macquarie Place
City: Sydney
State: new south wales
Zip: 2000
Country: AU
Regal Funds Management aims to provide investors with absolute returns over the medium to long term, through a suite of investment products in both listed and unlisted equities. The Regal Emerging Companies Fund focuses on Pre-IPO, later stage VC, expansion capital and listed micro-cap opportunities.
Contact Phone:
Contact Email:
Listed Exchange:
ASX
IPO Date:
5/30/2022
Ticker Symbol:
RPL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2020 | Forte | Seed Round | 5.6M |
12/2019 | 4DX | Convertible Note | 10.1M |
1/2018 | Lendi | Venture Round | 19.5M |
10/2020 | Global Study Partners | Convertible Note | - |
8/2019 | Equiem | Venture Round | 8.4M |
1/2022 | Buildxact | Series A | 0 |
11/2021 | ThinkMarkets | Debt Financing | 30M |
9/2021 | Till Payments | Series C | 0 |
5/2020 | Aroa Biosurgery Ltd | Series C | 0 |
2/2020 | DUG Technology | Convertible Note | 12.2M |
6/2017 | GetSwift | Post-IPO Equity | 18.2M |
12/2017 | Avoka | Venture Round | 16M |
11/2015 | Oventus Medical | Venture Round | 2.8M |
2/2021 | DesignCrowd | Venture Round | 7.6M |
7/2021 | DemystData | Funding Round | 24.7M |
8/2021 | Gelion Technologies | Convertible Note | 8.3M |
2/2021 | low6 | Convertible Note | - |
2/2023 | SendFX | Series B | 7.8M |
10/2018 | Life360 | Series D | 28M |
2/2019 | Oovvuu | Venture Round | 4.8M |
6/2016 | Avoka | Venture Round | 12M |
12/2016 | GetSwift | Private Equity Round | 5M |
11/2016 | Mpowermsl | Venture Round | 16M |
9/2019 | OpenLearning | Convertible Note | 1.7M |
6/2021 | Songtradr | Series D | 50M |
10/2021 | Superhero | Venture Round | 0 |
11/2018 | Sonder | Seed Round | - |
12/2020 | FiscalNote | Venture Round | 0 |
12/2021 | Access Telehealth | Funding Round | 0 |
7/2021 | Shaype | Series B | 12.6M |
11/2020 | Doctors on Demand | Convertible Note | 3.5M |
9/2021 | Xpansiv | Venture Round | 0 |
9/2022 | Shaype | Series C | 21.5M |
11/2022 | Nykaa | Post-IPO Secondary | 41.1M |
12/2016 | Zero Latency | Series B | 7M |
5/2021 | Artrya | Series A | 15M |
9/2022 | Platinum Asset Management | Private Equity Round | - |
7/2018 | Tic:Toc Home Loans | Series B | 11.5M |
6/2016 | Maestrano | Venture Round | 4M |
6/2018 | Credit Clear | Series A | 8.5M |
1/2017 | Credible | Series B | 10M |
8/2016 | Bigtincan | Series B | 4.6M |
11/2021 | Influential | Convertible Note | 15M |
9/2021 | Immutable Systems | Series B | 0 |
11/2020 | Metigy | Series B | 0 |
10/2020 | Lumos Diagnostics | Convertible Note | 17.8M |
4/2021 | Gefen | Convertible Note | 1.9M |
10/2020 | Yandal Resources | Post-IPO Equity | 4.2M |
12/2021 | Canopy Tools Group | Convertible Note | 0 |
6/2019 | AEROmetrex | Convertible Note | 4.9M |
6/2020 | Doctor Care Anywhere | Convertible Note | 17M |
3/2021 | Baraja | Series B | 30.4M |
9/2021 | Cover Genius | Series C | 0 |
8/2016 | Visioneering | Series B | 9M |
7/2021 | Butn | Corporate Round | 15M |
4/2017 | Nitro | Series C | 15M |
8/2019 | Quadpay | Series A | 9 |
9/2021 | Immutable | Series B | 0 |
8/2021 | Triad Life Sciences | Venture Round | 18.3M |
11/2021 | Packform | Venture Round | 17.8M |
8/2021 | Open | Series B | 31M |
2/2021 | Canopy Tools Group | Convertible Note | 16M |
8/2019 | DroneShield | Post-IPO Equity | 6.5M |
11/2019 | Cover Genius | Series B | 0 |
3/2022 | canibuild | Series A | 0 |
12/2021 | Mosh | Convertible Note | 0 |
11/2019 | Enlitic | Series B | 25M |
8/2017 | LiveTiles | Post-IPO Equity | 11M |
9/2015 | LiveTiles | Post-IPO Equity | 8.6M |
9/2021 | ZestMoney | Series C | 0 |
8/2021 | Alex | Series C | 14.7M |
3/2022 | canibuild | Series A | 0 |
1/2022 | Buildxact | Series A | 0 |
12/2021 | Access Telehealth | Funding Round | 0 |
12/2021 | Mosh | Convertible Note | 0 |
12/2021 | Canopy Tools Group | Convertible Note | 0 |
11/2021 | Packform | Venture Round | 0 |
11/2021 | ThinkMarkets | Debt Financing | 0 |
11/2021 | Influential | Convertible Note | 0 |
10/2021 | Superhero | Venture Round | 0 |
9/2021 | Till Payments | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|